Platelet thromboxane (11-dehydro-Thromboxane B2) and aspirin response in patients with diabetes and coronary artery disease

Figure 2 Distribution of baseline (aspirin-free) urinary 11-dehydro-thromboxane B2 levels (pg/mg) measured in healthy individuals and diabetes patients (A, top), and frequency distribution (histogram) of baseline urinary 11-dehydro-thromboxane B₂ levels in the two groups studied (B, bottom). A: Comparison of baseline 11-dehydro-thromboxane B₂ levels of diabetes and controls; B: Frequency (Histogram) of baseline 11-dehydro-thromboxane B2 levels in diabetes and controls.